Table 2.
PublicationYear | Source | Stimulator | Cell | Outcomes | Target | Ref |
---|---|---|---|---|---|---|
2016 |
O. keta & O. mykiss |
- | Mel-Ab & Co-culture of human melanocyte- keratinocyte model |
↓ Synthesis of melanin ↓ Intracellular activity of tyrosinase ↓ Protein expression of MITF, tyrosinase, and TRP-1 ↑ Phosphorylation of ERK and AKT |
Etc | [20] |
2016 | O. keta | - | U2OS &HDF | ↑ Cell motilities | Wound healing |
[8] |
2017 | O. mykiss |
E. coli LPS (1& 10 ng/mL) |
RAW 264.7 | ↓ Production of NO ↓ Secretion of IL-12 and TNF-α ↑ Secretion of IL-10 and VEGF-A |
Inflammatory disease | [19] |
2018 | O. keta | IL-1β (10 ng/mL) |
SW1353 | ↓ mRNA expression of CCL3, CCL4, CCL8, CXCL10, CXCL11, IL-1β, IL-6, IL-8, and TLR3 ↓ Protein level of CCL3, IL-1β, IL-6, and IL-8 |
Inflammatory disease | [17] |
2018 | O. keta | H2O2 (2 mM) | CHON-001 | ↓ Cell damage induced by H2O2 ↓ Expression of COX-2, PGE2 and TNF-α |
Degenerative joint disease | [21] |
2018 | O. keta | ZA (10 μM) & E. coli LPS (0.1 μg/mL) |
RAW 264.7 | ↑ Cell viability ↓ Production of NO ↓ Expression of IL-1β, IL-6, iNOS, and TNF-α ↑ Expression of VEGF and A2AR |
Inflammatory disease | [18] |
2018 | IL-1β (10 ng/mL) | SW1353 | ↑ Protein expression of aggrecan, ANG-2, PDGF, and VEGF ↓ Protein expression of endostatin, angiostatin, and MMP13 ↑ Cell migration |
Degenerative joint disease | [22] | |
2018 | O. keta | - | CCD-986SK | ↑ Phosphorylation of ERK, FAK, and JNK ↑ Cell migration |
Wound healing | [27] |
2019 | O. keta | - | HGF (neonatal) | ↑ Cell proliferation ↑ Expression of VEGF and CD31 |
Wound healing | [28] |
2019 | O. keta | E. coli LPS (1 μg/mL) | SH-SY5Y | ↑ Cell proliferation ↓ Production and expression of IL-1β, IL-6, and TNF-α ↑ Phosphorylation of CREB and cAMP ↑ Expression of BDNF, cAMP and VEGF |
Inflammatory disease | [25] |
2020 | O. keta |
E. coli LPS (1 μg/mL) & TGF-β (5 ng/mL) |
A549 | ↑ Cell viability reduced by LPS and TGF-β ↓ Expression of CTGF and hydroxyproline ↓ Expression of COL I, FGF, IL-6, and TNF-α |
Etc | [24] |
2020 | O. keta | - | HDF & Diabetic HDF & HUVECs |
↑ Cell proliferation and migration ↑ Expression of FGF and VEGF ↑ Vessel formation and density ↑ Total vessel network length |
Wound healing | [8] |
2020 | O. keta | - | B16-F10 & CCD-986SK |
↓ Activity of mushroom tyrosinase and the cellular tyrosinase ↓ Intracellular content and cellular level of melanin ↓ mRNA and protein expression of MITF, tyrosinase, TRP1, and TRP2 ↑ Mitochondrial density and the mtDNA contents ↓ Activity of in vitro collagenase and elastase ↓ Level of cellular MMP1 ↑ mRNA expression for mtDNA Antioxidant activity |
Etc | [23] |
2020 | O. keta | PM10 (100 μg/mL) |
NCI-H358 | ↓ Cytotoxicity induced by PM10 ↑ Concentration of cAMP ↓ Level of Caspase-3 and -9, IL-1β, IL-6, and TNF-α ↑ Phosphorylation of CREB and PKA ↓ Expression ration of Bax/Bcl-2 ↓ Expression of Cyt c and Apaf-1 |
Etc | [16] |
↓: Decrease ↑: Increase.